Brief: Agile Therapeutics Estimates Net Sales In Q3 Of 2021 Will Be In Range Of $1.4 Million To $1.6 Million
Sept 10 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS - ESTIMATES NET SALES IN Q3 OF 2021
WILL BE
IN RANGE OF $1.4 MILLION TO $1.6 MILLION
* AGILE THERAPEUTICS - ESTIMATES RETAIL UNITS SOLD BASED ON
TOTAL
PRESCRIPTION DEMAND WILL BE 9,500 TO 10,000 IN Q3 2021
Source: [ID:https://bit.ly/3A2mC95]
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt